CAJ | 학술논문

目的：探讨血清白细胞介素-6（interleukin, IL-6）在胆管癌疾病中临床意义。方法：选择30例胆管良性疾病患者，25例胆管癌患者，20例健康者。采用ELISA双抗体夹心法测血清IL-6的水平变化。结果：25例胆管癌患者血清中IL-6水平明显高于胆管良性疾病及健康者（P＜0.05），胆管癌手术后血清IL-6水平明显低于手术前，有显著差异（P＜0.05）。结论：胆管癌患者血清IL-6水平明显增高，检测血清IL-6可做为诊断胆管癌重要指标。
목적：탐토혈청백세포개소-6（interleukin, IL-6）재담관암질병중림상의의。방법：선택30례담관량성질병환자，25례담관암환자，20례건강자。채용ELISA쌍항체협심법측혈청IL-6적수평변화。결과：25례담관암환자혈청중IL-6수평명현고우담관량성질병급건강자（P＜0.05），담관암수술후혈청IL-6수평명현저우수술전，유현저차이（P＜0.05）。결론：담관암환자혈청IL-6수평명현증고，검측혈청IL-6가주위진단담관암중요지표。
Objective: To explore the clinical significance. Methods: The double-antibody sandwich ELISA technique. Result: The serum interleukin-6(IL-6) levels of patients with cholangiocarcinoma are significantly higher than those in benign biliary disease and normal controls (P<0.05). Conclusion: Serum IL-6 levels of patients with cholangiocarcinoma are significantly increased ,it is one of the important parameters for clinical evaluation in patients of cholangiocarcinoma.